IO Frontiers World 2019


Timothy Fisher

Timothy Fisher

Global Lead, Search & Evaluation, Oncology, Bristol Myers Squibb

Tim Fisher is Global Lead, Immuno-Oncology / Oncology in Search & Evaluation at BMS. He has been working in the pharmaceutical industry for 12 years as both a researcher and business development professional. He works with senior R&D and commercial leadership to design and execute the business development strategy for Immuno-Oncology and Oncology.

He joined the Search & Evaluation group of Bristol-Myers Squibb in 2014. Prior to joining BMS he was at Merck, where he led business development efforts in cardiovascular disease, new technologies and oncology. He received his doctorate at the Albert Einstein College of Medicine and postdoctoral training at Princeton University.

  • "Great venue to solidify and harmonize on the current challenges facing this sector - in real time. The caliber of the speakers and session contents was premier. “
    Dolores Baksh
    Innovation Leader, GE Healthcare
  • “A great event to learn about the hurdles that are needed to be overcome to get through the clinic.”
    Devin Bridgen
    Scientist, strategic partnerships, SQZ Biotech
  • "It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer."
    Lance Leopold
    Vice President, Head of Oncology Development, Incyte Corporation
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • “In the rapidly moving Advanced Therapy market, Phacilitate remains one of the premier events.”
    David James
    CEO, Scinogy